Slide 1: Q1 2026 Conference Call
Q1 2026 Conference Call May 5, 2026
Slide 2: Forward-looking statement
Forward-looking statement Disclaimer This presentation includes forward-looking statements, including statements relating to the operating, financial and sustainability performance and results of the group and/or the industry in which it operates. Forward-looking statements include, without limitati
Slide 3: Group
Food & Health Group Biosolutions 44% 56% 7% 37.8% Planetary Health Biosolutions Organic sales growth Adj. EBITDA margin Group sales and organic sales growth y/y EURm • Organic sales growth against high comparable +7% OSG • Volumes +6% including ~1pp from synergies • Pricing +1% 1,077.6 1,119.3 • Inc
Slide 4: Food & Health Biosolutions
Food & Health Human Health 25% Biosolutions 75% Food & Beverages Q1 2026 Divisional sales and organic sales growth y/y • 9% organic sales growth (including ~3pp effect from EURm exiting certain countries), driven by both Food & +9% OSG Beverages and Human Health • Growth mainly driven by volumes inc
Slide 5: Food & Beverages and Human Health
Food & Beverages Human Health Q1 2026 Q1 2026 • 11% organic sales growth • 5% organic sales growth (including ~4pp effect from exiting certain countries) (including ~1pp effect from exiting certain countries) • Growth across all industries, led by Dairy • Growth driven by Advanced Health & Nutrition
Slide 6: Planetary Health Biosolutions
Planetary Health Household Care 35% Biosolutions 65% Agriculture, Energy & Tech Q1 2026 Divisional sales and organic sales growth y/y • 5% organic sales growth driven by both Household EURm Care and Agriculture, Energy & Tech against high +5% OSG comparables • Growth mainly driven by volume, support
Slide 7: Household Care and Agriculture, Energy & Tech
Household Care Agriculture, Energy & Tech Q1 2026 Q1 2026 • 4% organic sales growth against a high comparable • 5% organic sales growth against a high comparable, driven by strong growth in Energy and Agriculture, while Tech declined • Growth driven by innovation and increased penetration of local &
Slide 8: Financial results Q1 2026
Financial results Q1 2026 • 7% broad-based organic sales growth • 37.8% adj. EBITDA margin impacted by year-on-year currency headwinds • +8% increase in adj. EPS excl. PPA • +9% FCF before acquisitions at EUR 74.0 million • Successful inaugural bond issuance of EUR 1.7 billion completed Q1 2026 Q1 2
Slide 9: Outlook 2026
Outlook 2026 • Organic sales growth of 5-7% (6-8% excl. exiting certain countries) 2026 growth components: • 5-7% volume, including ~ 1 pp from synergies • A good 1 pp from price • Close to 1 pp effect from exiting certain countries • Adjusted EBITDA margin between 37-38% with expected margin expans
Slide 10: Q&A
Q&A
Slide 11: Organic sales performance by region
Organic sales performance by region Developed markets Q1 2026: +8% North America Europe, the Middle East & Africa Q1 2026: +7% Q1 2026: +5%* 63% 30% Asia Pacific of sales of sales 36% of sales Q1 2026: +6% Emerging markets Q1 2026: +4%* Latin America 19% of sales Q1 2026: +14% 37% of sales 15% of sa